Clinical & Experimental Metastasis

Papers
(The H4-Index of Clinical & Experimental Metastasis is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis55
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression41
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG32
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics30
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption28
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches26
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics26
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss25
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria25
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection25
Oncolytic intralesional therapy for metastatic melanoma25
Cell blebbing novel therapeutic possibilities to counter metastasis20
Axillary nodal staging in breast cancer: what have we learned?19
Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells19
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions19
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer19
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations17
0.092660903930664